COMPANY
Hager Biosciences, LLC
NIH awards 5
- NIH award 1R43AG085864-01A1 FY2024: $499,968 awarded for that fiscal year; activity R43 (SBIR); PI BUTERA, JOHN A; recipient as written: HAGER BIOSCIENCES, LLC, BETHLEHEM, PA. Optimization of Novel Potassium Channel source ↗
- NIH award 1UF1DA054817-01A1 FY2021: $5,598,515 awarded for that fiscal year; activity UF1 (OTHER_NIH); PI BUTERA, JOHN A; recipient as written: HAGER BIOSCIENCES, LLC, BETHLEHEM, PA. Preclinical Development of Novel source ↗
- NIH award 1R43NS093724-01 FY2015: $224,995 awarded for that fiscal year; activity R43 (SBIR); PI BUTERA, JOHN A; recipient as written: HAGER BIOSCIENCES, LLC, BETHLEHEM, PA. Multi-targeted Ligands to Treat Chronic Ne source ↗
- NIH award 1R43ES023773-01 FY2013: $374,488 awarded for that fiscal year; activity R43 (SBIR); PI BUTERA, JOHN A; recipient as written: HAGER BIOSCIENCES, LLC, BETHLEHEM, PA. Multi-targeted Countermeasures against Acu source ↗
- NIH award 1R41DA032463-01 FY2011: $299,973 awarded for that fiscal year; activity R41 (STTR); PI MEKONNEN, BELEW; recipient as written: HAGER BIOSCIENCES, LLC, BETHLEHEM, PA. Developing Novel Dual CRF-R1/Orexin-1 Rec source ↗